JARID2 and cancer: In this study, we provide evidence on the direct relationship between epigenetic modifiers, JARID2 and the PRC2 complex, and a canonical Wnt signaling regulator, SFRP1, that are significantly correlated in cancer patients and significantly associated with the lifespan and overall survival of these patients.